rethinkMushrooms Search
Menu
Research citation

Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation.

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation.

Lipids in health and disease, 23(1), 395

Citation

Lv, Xiaoyu; Nie, Chenyu; Shi, Yihan; Qiao, Qincheng; Gao, Jing; Zou, Ying; Yang, Jingwen; Chen, Li; Hou, Xinguo. (2024). Ergothioneine ameliorates metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) by enhancing autophagy, inhibiting oxidative damage and inflammation.. Lipids in health and disease, 23(1), 395. https://doi.org/10.1186/s12944-024-02382-9